Connection

Marcel Müller to Humans

This is a "connection" page, showing publications Marcel Müller has written about Humans.
Connection Strength

0.108
  1. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat Commun. 2021 06 21; 12(1):3818.
    View in: PubMed
    Score: 0.008
  2. The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species. PLoS Pathog. 2018 09; 14(9):e1007296.
    View in: PubMed
    Score: 0.006
  3. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015 May; 15(5):559-64.
    View in: PubMed
    Score: 0.005
  4. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis. 2014 Aug; 20(8):1319-22.
    View in: PubMed
    Score: 0.005
  5. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014 Dec 19; 194:175-83.
    View in: PubMed
    Score: 0.005
  6. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol. 2013 Nov; 87(22):12489-95.
    View in: PubMed
    Score: 0.004
  7. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. mBio. 2012 Dec 11; 3(6).
    View in: PubMed
    Score: 0.004
  8. Human coronavirus NL63 open reading frame 3 encodes a virion-incorporated N-glycosylated membrane protein. Virol J. 2010 Jan 15; 7:6.
    View in: PubMed
    Score: 0.003
  9. Plaque assay for human coronavirus NL63 using human colon carcinoma cells. Virol J. 2008 Nov 12; 5:138.
    View in: PubMed
    Score: 0.003
  10. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science. 2021 10 08; 374(6564):eabh1823.
    View in: PubMed
    Score: 0.002
  11. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021 Oct; 27(10):1520.e7-1520.e10.
    View in: PubMed
    Score: 0.002
  12. Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany. Nat Commun. 2021 04 09; 12(1):2117.
    View in: PubMed
    Score: 0.002
  13. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients. Front Immunol. 2021; 12:629185.
    View in: PubMed
    Score: 0.002
  14. Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures. J Clin Virol. 2021 05; 138:104796.
    View in: PubMed
    Score: 0.002
  15. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol. 2020; 11:628971.
    View in: PubMed
    Score: 0.002
  16. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020 11; 587(7833):270-274.
    View in: PubMed
    Score: 0.002
  17. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature. 2020 09; 585(7826):588-590.
    View in: PubMed
    Score: 0.002
  18. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients. Emerg Infect Dis. 2020 Jul; 26(7):1478-1488.
    View in: PubMed
    Score: 0.002
  19. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature. 2020 06; 582(7813):561-565.
    View in: PubMed
    Score: 0.002
  20. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020 05; 581(7809):465-469.
    View in: PubMed
    Score: 0.002
  21. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 04 16; 181(2):271-280.e8.
    View in: PubMed
    Score: 0.002
  22. Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence. Elife. 2020 02 03; 9.
    View in: PubMed
    Score: 0.002
  23. Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus. Emerg Microbes Infect. 2020; 9(1):155-168.
    View in: PubMed
    Score: 0.002
  24. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nat Commun. 2019 12 18; 10(1):5770.
    View in: PubMed
    Score: 0.002
  25. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2019 10; 25(10):1878-1883.
    View in: PubMed
    Score: 0.002
  26. Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar. J Immunol Res. 2019; 2019:1386740.
    View in: PubMed
    Score: 0.002
  27. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization. J Virol. 2019 01 15; 93(2).
    View in: PubMed
    Score: 0.002
  28. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience. Antivir Ther. 2018; 23(7):617-622.
    View in: PubMed
    Score: 0.002
  29. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity. Diagn Microbiol Infect Dis. 2017 Oct; 89(2):106-111.
    View in: PubMed
    Score: 0.001
  30. No Serologic Evidence of Middle East Respiratory Syndrome Coronavirus Infection Among Camel Farmers Exposed to Highly Seropositive Camel Herds: A Household Linked Study, Kenya, 2013. Am J Trop Med Hyg. 2017 Jun; 96(6):1318-1324.
    View in: PubMed
    Score: 0.001
  31. Serologic Evaluation of MERS Screening Strategy for Healthcare Personnel During a Hospital-Associated Outbreak. Infect Control Hosp Epidemiol. 2017 02; 38(2):234-238.
    View in: PubMed
    Score: 0.001
  32. Link of a ubiquitous human coronavirus to dromedary camels. Proc Natl Acad Sci U S A. 2016 08 30; 113(35):9864-9.
    View in: PubMed
    Score: 0.001
  33. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci U S A. 2016 08 30; 113(35):E5192-201.
    View in: PubMed
    Score: 0.001
  34. MERS-CoV Antibodies in Humans, Africa, 2013-2014. Emerg Infect Dis. 2016 06; 22(6):1086-9.
    View in: PubMed
    Score: 0.001
  35. Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection. Clin Infect Dis. 2016 Feb 15; 62(4):477-483.
    View in: PubMed
    Score: 0.001
  36. Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014. Emerg Infect Dis. 2015 Aug; 21(8):1422-5.
    View in: PubMed
    Score: 0.001
  37. Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia. J Clin Microbiol. 2015 Sep; 53(9):2951-5.
    View in: PubMed
    Score: 0.001
  38. CD26/DPP4 cell-surface expression in bat cells correlates with bat cell susceptibility to Middle East respiratory syndrome coronavirus (MERS-CoV) infection and evolution of persistent infection. PLoS One. 2014; 9(11):e112060.
    View in: PubMed
    Score: 0.001
  39. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014 Aug 28; 371(9):828-35.
    View in: PubMed
    Score: 0.001
  40. Inhibition of proprotein convertases abrogates processing of the middle eastern respiratory syndrome coronavirus spike protein in infected cells but does not reduce viral infectivity. J Infect Dis. 2015 Mar 15; 211(6):889-97.
    View in: PubMed
    Score: 0.001
  41. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis. 2014 Jun; 20(6):1012-5.
    View in: PubMed
    Score: 0.001
  42. Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus. PLoS Pathog. 2014 May; 10(5):e1004166.
    View in: PubMed
    Score: 0.001
  43. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol J. 2013 Dec 23; 10:359.
    View in: PubMed
    Score: 0.001
  44. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis. 2014 Jan 15; 209(2):243-6.
    View in: PubMed
    Score: 0.001
  45. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013 Oct; 13(10):859-66.
    View in: PubMed
    Score: 0.001
  46. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013 Sep; 13(9):745-51.
    View in: PubMed
    Score: 0.001
  47. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013 Mar 14; 495(7440):251-4.
    View in: PubMed
    Score: 0.001
  48. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio. 2013 Feb 19; 4(1):e00611-12.
    View in: PubMed
    Score: 0.001
  49. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res. 2012 Apr; 165(1):112-7.
    View in: PubMed
    Score: 0.001
  50. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 2011 Oct; 7(10):e1002331.
    View in: PubMed
    Score: 0.001
  51. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol. 2011 Dec; 85(24):13363-72.
    View in: PubMed
    Score: 0.001
  52. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011 May; 85(9):4122-34.
    View in: PubMed
    Score: 0.001
  53. Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg Infect Dis. 2009 Sep; 15(9):1377-84.
    View in: PubMed
    Score: 0.001
  54. Human coronavirus NL63 and 229E seroconversion in children. J Clin Microbiol. 2008 Jul; 46(7):2368-73.
    View in: PubMed
    Score: 0.001
  55. Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections. Virol J. 2005 Feb 10; 2:7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.